• info@aphrc.org
  • infowestafrica@aphrc.org

DURABILITY OF FIRST LINE ANTIRETROVIRAL THERAPY: REASONS AND PREDICTIVE FACTORS FOR MODIFICATIONS IN A SWAZILAND COHORT

Share:
Facebook
X
LinkedIn

Related Publications